Half Year 2026 Eurofins Scientific SE Earnings Call Transcript
Key Points
- Eurofins Scientific SE (ERFSF) reported a strong improvement in results with a 29% EPS growth, continuing the progress seen in margins and profit over the last year.
- The company achieved a 23.7% adjusted EBITDA margin, surpassing their objectives, even in what is traditionally a lower margin part of the year.
- Eurofins Scientific SE (ERFSF) is seeing benefits from its hub-and-spoke model and IT solutions deployment, which are expected to be completed by the end of 2027, enhancing efficiency.
- The company has successfully divested its electrical and electronic testing business, allowing it to focus more on its core Testing for Life business.
- Eurofins Scientific SE (ERFSF) has seen strong revenue growth in the rest of the world, with a 9% organic increase and a 5% reported increase, alongside significant margin improvements across all regions.
- Growth is still not at Eurofins Scientific SE (ERFSF)'s mid-term objectives, with organic growth at only 2.7% and facing a strong FX headwind of 2.9%.
- The biopharma sector remains soft, with some large contracts ending and not yet replaced, impacting growth, especially in Europe.
- The diagnostics business in North America experienced negative growth due to regulatory changes affecting transplant business and donor product testing.
- Eurofins Scientific SE (ERFSF) is still facing significant expenses and disruptions from deploying new IT solutions in its food and environmental testing businesses in Europe.
- The company is still in the process of rationalizing sites and capacity in agroscience and genomics, which are challenged on the top-line.
(Operator Instructions) Good day, ladies and gentlemen, and welcome to the Eurofins H1 2026 conference call. (Operator Instructions) It is now my pleasure to turn the floor over to your host, Mr. Andrew Swift. Sir, the floor is yours.
Thank you for joining the Eurofins H1 2026 conference call. Please note that this call is being recorded and will later be available for replay on the Eurofins Investor Relations website. Throughout today's presentation, all participants will be in the listen-only mode. (Event instructions) During this call, Eurofins management may make forward-looking statements, including but not limited to statements with respect to outlook and the related assumptions. Management will also discuss alternative performance measures such as organic growth and EBITDA, which are defined in the footnotes of our press releases.
Actual results may differ materially from objectives discussed. Risks and uncertainties that may affect Eurofin's future results include, but are not limited to, those described in the Risk
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
